Donald Engelman
Donald Max Engelman is Higgins Professor of Biochemistry at Yale University. He is a member of the National Academy of Sciences, fellow of the American Academy of Arts and Sciences, a fellow of the National Institutes of Health, and has been a Guggenheim fellow. He served as the editor of the Annual Review of Biophysics and Biophysical Chemistry .
He is a director of the Stryker Corporation. He is involved in the creation of new cancer drugs and treatments. For example, Engelman is involved in research to use peptides to aid in destroying tumors.